You are here: Home > Results > Grants Funded

Grants Funded

Since 2008, support from Good Cookies like YOU has helped Cookies for Kids' Cancer fund 4 DOZEN childhood cancer research grants, leading to 9 promising new treatments now in clinical trial, available to children fighting cancer TODAY.

Research Grants Funded to Date:

AMOUNT CENTER RESEARCHER GRANT

2013

$100,000

Children's Hospital Of Philadelphia

Dr. Nichols

Novel cell-based therapy for b cell leukemias and lymphomas

$100,000

Children's Hospital Of Philadelphia

Dr. Thomas-Tikhonenko

Decreasing resistance to chemotherapies in pediatric lymphomas, and decreasing sensitivities and effects related to the chemotherapy drug Doxorubicin

$350,000

Children's Oncology Group

A national effort to standardize surgical treatment for pulmonary metastasis in osteosarcoma

$100,000

Dana-Farber Cancer Institute

Dr. Stegmaier

New treatments for neuroblastoma by targeting the Epigenome

$450,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Retargeting t cells using bispecific antibody against receptor Tyrosine Kinase-like orphan receptors 2 (Ror2) in solid tumors

$100,000

St. Jude Children's Research Hospital

Dr. Inaba

Genetic characterization and therapeutic targeting of pediatric mixed phenotype acute leukemia

$100,000

Texas Children's Cancer Center

Dr. Berg

Phase I trial of Sgt-53, a novel nanoparticle therapy, for children with refractory or recurrent solid tumors

$100,000

Texas Children's Cancer Center

Dr. Metelitsa

Phase I clinical trial of a novel immune therapy using dual-specific Nkt cells for children with neuroblastoma

2012

$350,000

Children's Oncology Group

Matching federal funds per child enrolled in Phase I clinical trials

$100,000

Children's Hospital Of Philadelphia

Dr. Attiyeh

Xpo1 Inhibition in neuroblastoma

$100,000

Children's Hospital Of Philadelphia

Dr. Bassing

Targeting Bcl11b Haploin sufficient lymphoid tumors 6

$100,000

Dana-Farber Cancer Institute

Dr. Roberts

Targeting of Cdk4 signaling in pediatric Rhabdoid tumors

$100,000

Dana-Farber Cancer Institute

Dr. Galiando

Phase II study of clofarabine in refractory Langerhans cell histiocytosis

$100,000

Dana-Farber Cancer Institute

Dr. Shusterman

Csf producing whole tumor vaccine for neurblastoma

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Dual specific human monoclonal antibody targeting IGF-I and IGF-II for pediatric cancers

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Kramer

Delivery of 124-I-8h9 non-progressive diffuse Pontine Gliomas.

$100,000

St. Jude Children's Research Hospital

Dr. Furman

Hu14.18322a + Multi-Modality treatment for neuroblastoma

$100,000

Texas Children's Cancer Center

Dr. Gottschalk

Fap-targeted t cell therapy for osteosarcoma

2011

$100,000

St. Jude Children's Research Hospital

Dr. Gilbertson

Rapid and accurate diagnosis of Medolloblastoma subtypes in trials

$100,000

Children's Hospital Of Philadelphia

Dr. Maris

Molecular oncology for pediatric cancers

$100,000

Children's Hospital Of Philadelphia

Dr. Weiss

Modeling juvenile myelomonocytic Leukemia patient Ips cells

$100,000

Dana-Farber Cancer Institute

Dr. Stegmaier

Validation of fak therapeutic target in Ewings Sarcoma

$100,000

Dana-Farber Cancer Institute

Dr. George

Development of dendritic call vaccine against Alk-Positive

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

A safe, potent Saponin adjuvant for Gd2 conjugated vaccine for neuroblastoma

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. LaQuaglia

Phase I trial of Hepatic Artery Infusion/neuroblastoma tumors in the liver

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Bite Therapy

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Bite Therapy

$100,000

Texas Children's Cancer Center

Dr. Metelitsa

Immunotherapy of neuroblastoma with dual-specific Nkt cells

$100,000

Texas Children's Cancer Center

Dr. Nuchtern

Genomic anatomy of chemotherapy-resistant neuroblastoma

2010

$100,000

Children's Hospital Of Philadelphia

Dr. Grupp

Engineered T Cell Therapy For Recurrent Neuroblastoma & B Cell Malignancies

$100,000

Children's Hospital Of Philadelphia

Dr. Hogarty

Sirna based Kimome screen to id Mcl1 antagonists for resistant Tumors

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Bite Therapy, 2nd round of funding

$100,000

St Jude Children's Research Hospital

Dr. Bhojwani

CD-20 targeted immunotherapy for relapsed childhood neuroblastoma

$100,000

Texas Children's Cancer Center

Dr. Shohet

Therapy for relapsed neuroblastoma. P13k/Aktm tor pathway inhibition

$100,000

Texas Children's Cancer Center

Dr. Su

Therapy efficacy study for newly diagnosed brainstem gliomas

2009

$100,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Bite Therapy

$35,000

Texas Children's Cancer Center

Dr. Rabin

Novel therapy using JAK-STAT pathway inhibitors in childhood leukemias

$50,000

Texas Children's Cancer Center

Dr. Louis

A phase I/II study using allogenic tumor cell vaccination with oral metronomic cytoxan in patients with high-risk neuroblastoma

$150,000

Texas Children's Cancer Center

Two Grants

2008

$400,000

Memorial Sloan-Kettering Cancer Center

Dr. Cheung

Hu3f8 antibody treatment for neuroblastoma

Treatments Now in Clinical Trial:

Memorial Sloan-Kettering Cancer Center

HU3F8 antibody treatment

Saponin adjuvant for GD2 conjugate vaccine

Convection-enhanced delivery of 124I-8H9 Brainstem glioma

Children's Hospital of Philadelphia

Engineered t cell therapy - recurrent neuroblastoma & b cell malignancies

Phase I trial of MK1775, approved and activated for accrual

Texas Children's Cancer Center

Phase I/II trials of ABT-888 plus XRT - pediatric brain tumors

Immunotherapy with dual-specific NKT cells - Neuroblastoma

St. Jude Children's Research Hospital

CD-20 targeted therapy - Leukemia

Anti-GD2 monoclonal antibody therapy - Neuroblastoma